Abstract

The phenol equivalence assay is the current industry-adopted test used to quantify the antibacterial activity of honeys in Australia and New Zealand. Activity is measured based on the diffusion of honey through agar and resulting zone of growth inhibition. Due to differences in the aqueous solubilities of antibacterial compounds found in honeys, this method may not be optimal for quantifying activity. Therefore, a new method was developed based on the existing broth microdilution assay that is widely used for determining minimum inhibitory concentrations (MICs). It utilises the four organisms Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853, and an optical density endpoint to quantify bacterial growth. Decreases in bacterial growth in the presence of honey, relative to the positive growth control, are then used to derive a single value to represent the overall antibacterial activity of each honey. Antibacterial activity was quantified for a total of 77 honeys using the new method, the phenol equivalence assay and the standard broth microdilution assay. This included 69 honeys with undisclosed floral sources and the comparators Manuka, Jarrah (Eucalyptus marginata), Marri (Corymbia calophylla), artificial and multifloral honey. For the 69 honey samples, phenol equivalence values ranged from 0–48.5 with a mean of 34 (% w/v phenol). Mean MICs, determined as the average of the MICs obtained for each of the four organisms for each honey ranged from 7–24% (w/v honey). Using the new assay, values for the 69 honeys ranged from 368 to 669 activity units, with a mean of 596. These new antibacterial activity values correlated closely with mean MICs (R2 = 0.949) whereas the relationship with phenol equivalence values was weaker (R2 = 0.649). Limit of detection, limit of quantitation, measuring interval, limit of reporting, sensitivity, selectivity, repeatability, reproducibility, and ruggedness were also investigated and showed that the new assay was both robust and reproducible.

Highlights

  • Honey produced by the European honeybee Apis mellifera is well known to have antimicrobial activity

  • The quantities and types of phenolic compounds present in honeys derived from different floral sources can vary widely, and this directly impacts the characteristics of each honey, including taste and colour, and the level of antibacterial activity [2, 4]

  • We have shown in previous research that honeys may differ in both their capacity to generate hydrogen peroxide, and rate of hydrogen peroxide accumulation [42], which may impact results of antibacterial activity assays

Read more

Summary

Introduction

Honey produced by the European honeybee Apis mellifera is well known to have antimicrobial activity. In Australia and New Zealand the current industry-adopted commercial test for quantifying the antibacterial activity of honey is known as the phenol equivalence assay, and has been referred to as the Unique Manuka Factor (UMF) assay [1, 11]. The assay can be used to quantify “total activity” (TA) by testing honey alone, or to quantify “non-peroxide activity” (NPA) after the addition of catalase to each honey solution to remove hydrogen peroxide activity This residual, or non-peroxide activity, is most commonly found in honeys derived from Leptospermum species, and as such has been referred to as the Unique Manuka Factor or UMF [10, 15, 16]. This trademarked measurement has been used extensively in the marketing of Manuka honeys

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call